ReviewExpert opinion on investigational drugs2021

MK-6482 as a potential treatment for von Hippel-Lindau disease-associated clear cell renal cell carcinoma.

Elshad Hasanov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.